Free Trial

Radiopharm Theranostics (RADX) News Today

Radiopharm Theranostics logo
$4.25 -0.34 (-7.41%)
Closing price 04:00 PM Eastern
Extended Trading
$4.31 +0.06 (+1.44%)
As of 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

RADX Latest News

Radiopharm Theranostics Reports Business Update
RADX: RAD 101 Phase IIb Interim Analysis
RAD Increases Ownership in Radiopharm Ventures to 87.5%
RADX: Interim Readout Achieves 92% Concordance
RADX: RAD101: Imaging Recurring Brain Metastases
Get Radiopharm Theranostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RADX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RADX Media Mentions By Week

RADX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RADX
News Sentiment

0.84

0.56

Average
Medical
News Sentiment

RADX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RADX Articles
This Week

0

2

RADX Articles
Average Week

Get the Latest News and Ratings for RADX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Radiopharm Theranostics and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:RADX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners